Preferred Label : Lisdexamfetamine Dimesylate;

MeSH definition : A dextroamphetamine drug precursor that also functions as a CENTRAL NERVOUS SYSTEM STIMULANT and DOPAMINE UPTAKE INHIBITOR and is used in the treatment of ATTENTION DEFICIT HYPERACTIVITY DISORDER.;

MeSH synonym : Dimesylate, Lisdexamfetamine; Lis-dexamfetamine Dimesylate; Dimesylate, Lis-dexamfetamine; Lis dexamfetamine Dimesylate;

MeSH Hyperonym : lisdexamfetamine;

MeSH hyponym : elvanse; vyvanse; NRP104; NRP-104; NRP 104;

MeSH Related Number : H645GUL8KJ;

Wikipedia link : https://en.wikipedia.org/wiki/Elvanse;

Is substance : O;

UNII : SJT761GEGS;

Details


Main resources

You can consult :

A dextroamphetamine drug precursor that also functions as a CENTRAL NERVOUS SYSTEM STIMULANT and DOPAMINE UPTAKE INHIBITOR and is used in the treatment of ATTENTION DEFICIT HYPERACTIVITY DISORDER.

https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/portraits-decrivant-les-interventions-pharmacologiques-et-non-pharmacologiques-entourant-le-trouble-du-deficit-de-lattention-avec-ou-sans-hyperactivite-tdah-chez-les-quebecois-de-25-ans-et-moins.html
2017
false
false
false
Canada
French
practice guideline
attention deficit disorder with hyperactivity
child
adolescent
young adult
quebec
review of literature
central nervous system stimulants
methylphenidate
dextroamphetamine
Delayed-Action preparations
Lisdexamfetamine Dimesylate
Atomoxetine Hydrochloride
centrally acting sympathomimetics
age factors
sex factors
drug utilization
drug utilization

---
https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/vyvanse-3432.html
2016
false
Canada
French
English
Lisdexamfetamine Dimesylate
evaluation of the transparency committee
attention deficit disorder with hyperactivity
child
adolescent
lisdexamfetamine
central nervous system stimulants
prodrugs
treatment outcome
Cost-Benefit analysis
adult
clinical trials as topic
administration, oral
drug evaluation

---
Summary Basis of Decision (SBD) VYVANSE - lisdexamfetamine dimesylate
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailOne.php?lang=fr&linkID=SBD00311
2010
false
Canada
French
English
Lisdexamfetamine Dimesylate
drug approval
canada
attention deficit disorder with hyperactivity
prodrugs
central nervous system stimulants
capsules
administration, oral
child
lisdexamfetamine
drug information

---
https://www.cadth.ca/sites/default/files/cdr/complete/cdr_complete_Vyvanse-December-18-2009_f.pdf
2009
false
Canada
French
Lisdexamfetamine Dimesylate
Lisdexamfetamine Dimesylate
attention deficit disorder with hyperactivity
canada
insurance, health, reimbursement
child
randomized controlled trials as topic
Cost-Benefit analysis
treatment outcome
lisdexamfetamine
drug evaluation

---
Nous contacter.
03/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.